• Startup founded by ShanghaiTech undergraduates receives seed and angel financing
    Recently, SynMeta bio, a startup founded by two senior undergraduate students in SLST of ShanghaiTech University, has completed seed and angel rounds of financing, totaling tens of millions RMB. Specifically, the seed round was led by Miracleplus, and the angel round was led by Linear Capital, with Miracleplus, Danen Capital and K2VC following up. Being...
    2023-03-23
  • Delegation from the University of Waikato Visits ShanghaiTech
    On March 10, President Jiang Mianheng met with Professor Alister Jones, Senior Deputy Vice-Chancellor of the University of Waikato in New Zealand.   President Jiang extended a warm welcome to Professor Jones and his colleague Mulan Mu, Associate Director of Global Programs of the University of Waikato. The University of Waikato is one of the top universities in New Zealand, said Pre...
    2023-03-17
  • Photonic microwave phased array: lighting the way to the next generation of 6G wireless networks
    The upcoming 6G wireless network poses numerous challenges, including continuous space coverage, hybrid near-/far-field beamforming, multi-user positioning/sensing, and holographic multiple-in-multiple-out (MIMO), and requires economical antenna solutions. Low-cost, high-gain beam-steerable antennas are therefore in high demand to overcome these difficulties. Compared to conventional microstrip ph...
    2023-03-15
  • Advances in high performance circularly polarized light detection by ShanghaiTech
    The rosy clouds of dawn, the sunset glow, the hazy moonlight and the rainbow are all forms of light found in nature.From an optical point of view, natural light, which does not directly show polarization, is isotropic. When natural light passes through a linear polarizer, it becomes linearly polarized. Through a quarter-wave plate, the linearly polarized light then becomes circularly polarized. Ci...
    2023-03-08
  • New mechanism of asymmetric centrosome division in neural stem cells
    In multicellular organisms, the centrosome plays a critical role in development and tissue homeostasis. In various early embryos and stem cells, the centrosome regulates their polarized or asymmetric cell division. Centrosome dysfunction is linked to various diseases including cancer, microcephaly and ciliopathy. APC/C (Anaphase-Promotion Complex/cyclosome) is an evolutionarily conserved ubiquitin...
    2023-03-01
  • Protein quality control regulates stress granule homeostasis
    Stress granules are membraneless condensates of RNA and RNA-binding proteins formed in response to cell stress. New evidence of the relationship between stress granules and neurodegenerative diseases highlights their physiological importance. Therefore, understanding the mechanism of this association and determining the key players that control stress granule homeostasis are crucial to t...
    2023-02-16
  • Congratulations to ShanghaiTech undergraduates for winning the Bronze Medal in the University Physics Competition!
    Recently, results of the 2022 University Physics Competition (UPC) were unveiled. SPST undergraduate students Zhao Yanzhi, Zhai Yizhou, and Feng Yibo, who are in "3+1" exchange at UC Berkeley, formed a team and won a Bronze Medal in the UPC. This was the first time ShanghaiTech students participated in this international competition and they won a medal. The award certific...
    2023-02-14
  • Thailand Delegation from Ministry of Higher Education, Science, Research and Innovation visited ShanghaiTech
    On February 12, a delegation from the Ministry of Higher Education, Science, Research and Innovation (MHESI) of Thailand visited ShanghaiTech University. Led by Prof. Pasit Lorterapong, Deputy Permanent Secretary of MHESI, a group of 13 Thai guests were warmly welcomed by Dr. Jiang Ge, Vice President of ShanghaiTech, as well as Prof. Jiang Biao, Distinguished Adjunct Professor of Shanghai Institut...
    2023-02-14
  • ShanghaiTech’s research findings selected among China’s Top 10 Advances in Life Sciences for the fourth straight year
    On January 19, two ShanghaiTech’s research findings were selected among “China’s Top 10 Advances in Life Sciences in 2022” as the list unveiled by the China Association for Science and Technology. The “world’s first ‘Perturb-Atlas’ for deciphering gene function” achieved by the group of Professor Chi Tian from SLST was selected, putting ShanghaiTech’s research achievements selected ...
    2023-01-21
  • Study reveals Mn-containing nanoparticles to inhibit osteosarcoma
    Osteosarcoma is the most common primary malignant tumor of bone, mostly seen in children and adolescents. Comprehensive treatment options for osteosarcoma have not evolved significantly in the last 30 years, and there is an urgent need to explore new therapies. Osteosarcoma is highly malignant, prone to metastasis, and has a poor prognosis. Traditional standard treatment of osteosarcoma relie...
    2022-12-29
  • Coffee meeting for international faculty to strengthen communication
    On December 7, 2022, a coffee meeting for international faculty was held on the second floor of the NestArt Coffee. This meeting was jointly organized by the Office of Human Resources and the Office of International Affairs (OIA), aiming at strengthening the connection between international faculty and the administration and creating a more international environment. Around 20 international facult...
    2022-12-28
  • Jing Medicine's HJM-353 obtains approvals for clinical trials in both China and U.S.
    Jing Medicine's embryonic ectoderm development (EED) inhibitor HJM-353 recently obtained approvals for clinical trials in both China and the United States. This is a major milestone in the transformation project signed between ShanghaiTech and Jing Medicine in 2019. It is also the first time that a transformation project of ShanghaiTech obtained approvals for clinical trials in both China and ...
    2022-12-23
  • ShanghaiTech, Grenoble INP and ENSCM hold an online cooperation launching ceremony
    On August 22, 2022, ShanghaiTech University signed a letter of intent (LOI) with Institut polytechnique de Grenoble (Grenoble INP - UGA, France) and École Nationale Supérieure de Chimie de Montpellier (ENSCM, France). Based on the LOI, ShanghaiTech and the two French institutions plan to carry out cooperation in several areas, including mutual visits of students and faculty, dual-degree prog...
    2022-12-22
  • ShanghaiTech-incubated Gluetacs Therapeutics obtains approval for clinical trial in China
    On December 20, GT919, the first molecular glue pipeline for oral administration of Gluetacs Therapeutics, a ShanghaiTech-incubated pharmaceutical company, obtained the implied permission for clinical trials from the Center for Drug Evaluation (CDE). Founded in 2020, Gluetacs has raised venture capital of more than 100 million yuan, and signed exclusive patent licensing agreements with ShanghaiTec...
    2022-12-21